ARTICLE | Clinical News
Glepaglutide: Completed Ph II enrollment
February 16, 2017 8:13 PM UTC
Zealand completed enrollment of about 18 patients in a double-blind, crossover, Danish Phase II trial evaluating 3 dose levels of subcutaneous glepaglutide given by an injectable pen device in 3-week ...
BCIQ Company Profiles
BCIQ Target Profiles